Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01319318 · ClinicalTrials.gov registry record
Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 25
- Enrollment target
NCT01319318 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 25 participants.
The verdict
NCT01319318 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.
Interventions
- PROCEDURE Pars Plana Vitrectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01319318
The ClinicalTrials.gov registry entry for NCT01319318 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pars Plana Vitrectomy is the first listed.
NCT01319318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01319318 about?
NCT01319318 is a clinical study titled "Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy". This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.
What is the current status of trial NCT01319318?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2011-03. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01319318?
The interventions under investigation include: Pars Plana Vitrectomy (PROCEDURE).
Who is sponsoring clinical trial NCT01319318?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.